9,10-dimethyl-1,2-benzanthracene has been researched along with rehmannic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bansal, MP; Sharma, M; Sharma, PD; Singh, J | 1 |
Bansal, MP; Kaur, J; Sharma, M; Sharma, PD | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and rehmannic acid
Article | Year |
---|---|
Synthesis, cytotoxicity, and antitumor activity of lantadene-A congeners.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Humans; Mice; Neoplasms, Experimental; Oleanolic Acid; Structure-Activity Relationship; Tumor Cells, Cultured | 2007 |
Chemopreventive activity of lantadenes on two-stage carcinogenesis model in Swiss albino mice: AP-1 (c-jun), NFkappaB (p65) and P53 expression by ELISA and immunohistochemical localization.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Cytoprotection; Enzyme-Linked Immunosorbent Assay; Esters; Female; Immunohistochemistry; Mice; NF-kappa B; Oleanolic Acid; Papilloma; Skin Neoplasms; Tissue Distribution; Transcription Factor AP-1; Tumor Suppressor Protein p53 | 2008 |